This sale reduced an insider's direct common stock position by 27%, though a majority of the position remains held through trusts and spousal holdings.
Encompass Health’s second quarter reflected robust demand for inpatient rehabilitation, with the company delivering revenue growth above Wall Street expectat...
Encompass Health (NYSE:EHC) reported second-quarter 2026 results marked by revenue, earnings and discharge growth, prompting the inpatient rehabilitation provider to raise its full-year outlook.
Revenue increased 9.6% from the prior-year quarter, while adjusted EBITDA rose 9.2% to $348 million and
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Health care services provider Encompass Health (NYSE:EHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.6% year on y...
What Happened? Shares of health care services provider Encompass Health (NYSE:EHC) jumped 13.2% in the afternoon session after the company reported second-qu...
Health care services provider Encompass Health (NYSE:EHC) announced better-than-expected revenue in Q2 CY2026, with sales up 9.6% year on year to $1.60 billi...
Health care services provider Encompass Health (NYSE:EHC) will be reporting earnings this Wednesday after market close. Here’s what to look for. Encompass He...
McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
One dominates kidney care with global reach, while the other leads in rehab with faster growth and higher margins. Which business model stands out for 2026?
Encompass Health currently trades at $103.99 per share and has shown little upside over the past six months, posting a small loss of 2.3%. The stock also fel...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Encompass Health’s first quarter results for 2026 were met with a notably positive market reaction, as the company’s revenue growth outpaced Wall Street expe...
